Healthcare

Nova Mentis (OTC: NMLSF) Study Confirms Oral Microdose Psilocybin Treatment of Autism

VANCOUVER, BC, Feb. 16, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased to announce […]

Newsmakers

DeepMarkit (OTC: MKTDF) Executes LOI with Top Energy Regarding the Minting of Clean Energy NFTs

Top Energy to Introduce and Onboard Carbon Credits Derived From Clean Energy Projects to the MintCarbon.io Platform of DeepMarkit’s Wholly Owned Subsidiary First Carbon Corp. CALGARY, AB, March 23, 2022 – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) […]

Financials

XTM (OTC: XTMIF) Secures Integration to 20 Point-of-Sale Systems (POS) and Time Tracking Software Accelerating U.S. Roll-out

XTM Gains Access to Multiple POS Systems Through a Single Integration MIAMI & TORONTO, March 21, 2022—XTM, Inc. (“XTM” or the “Company”) (QB: XTMIF / CSE:PAID / FSE:7XT), a Miami and Toronto-based Fintech company in […]

Newsmakers

NuRAN (OTC: NRRWF) Signs Final Agrrement with Afriland First Bank, Closes First Bridge Financing and Provides Corporate Update

QUEBEC, QC / March 18, 2022 / NuRAN Wireless Inc. (“NuRAN” or the “Company”) (CSE:NUR)(OTC PINK:NRRWF)(FSE:1RNA), a leading rural telecommunications company, is pleased to provide a corporate update on certain significant milestones for the Company and […]

Mining & Metals

FIRST ENERGY METALS (OTC: FEMFF) ADDS PROSPECTIVE GROUND TO ITS EXISTING LITHIUM FOOTPRINT IN QUEBEC

VANCOUVER, BC, March 21, 2022 – First Energy Metals Ltd. (CSE: FE) (“First Energy” or the “Company) is pleased to announce that it has signed a purchase agreement with a group of vendors to acquire the Electron Lithium Project […]

Newsmakers

Liquid Avatar Technologies (OTC: LQAVF) Launches First-Ever Payment Card and Loyalty Program for the Metaverse

Users Have the Opportunity to Earn Points and Cash Back while Participating in Quests and Games by Shopping in the Aftermath Islands Metaverse TORONTO, ON / March 21, 2022/Liquid Avatar Technologies Inc. (CSE:LQID)(OTCQB:LQAVF)(FRA:4T51) Liquid Avatar Technologies, […]

No Picture
Consumer

GenTech (OTC: GTEH) Updates Investors on the Growing Retail Footprint as Kroger’s VitaCost™ and Muscle & Strength™ Go Live with Fizzique™

GenTech Updates Investors on the Growing Retail Footprint as Kroger’s VitaCost™ and Muscle & Strength™ Go Live with Fizzique™ Wheat Ridge, COLORADO, March 22, 2022 — GenTech Holdings, Inc. (OTC: GTEH) (“GenTech” or the “Company”), […]

No Picture
Newsmakers

Blue Water (NASDAQ: BWV) Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility

Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform. The data supports BWV’s ongoing development of a transformational universal influenza vaccine, as well as […]

No Picture
Healthcare

Clarus (NASDAQ: CRXT) Announces Initiation of Phase 4 Clinical Trial of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadal Men with Chronic Kidney Disease

JATENZO is the first and only FDA-approved oral softgel for testosterone (T) replacement therapy in adult males who have deficient T due to certain medical conditions Clarus expects to announce results from the trial in […]

Newsmakers

DeepMarkit (OTC: MKTDF) Announces Strategic Investment and LOI with Malaysia-based Radiance Assets Berhad

Radiance purchased 2,450,000 units of the Company for a price of $0.85 per Unit, for gross proceeds of $2,082,500 Radiance to introduce Asia-based carbon credit projects to DeepMarkit’s subsidiary, First Carbon Corp., and its MintCarbon.io platform Carbon offset arrangement to […]

No Picture
Healthcare

Brickell Biotech (NASDAQ: BBI) Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral DYRK1A inhibitor, a portfolio of novel STING inhibitors, and a next-generation kinase inhibitor platform On […]

Healthcare

PharmaDrug (OTC: LMLLF) Announces Interim Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Prostate Cancer Study

Interim results show that oral cepharanthine plus cabazitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 21, the final day of dosing Dose range findings demonstrate that oral cepharanthine-alone was […]